Takeda Pharmaceutical Names U.S. Head Julie Kim as Next CEO
The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who ...
Kellogg School of Management3mon
Takeda’s Julie Kim ’97 MBA on driving toward a shared vision
When Julie Kim ’97 MBA graduated from the Kellogg School of Management, buzzwords like purpose, engagement and connection weren’t yet popular in professional circles. But in retrospect, she says, ...